Transcriptomic Analysis of the Amygdala in Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder Reveals Differentially Altered Metabolic Pathways.

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Schizophrenia bulletin

• Publication date

  2024-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/schbul/sbae193PMID 39526318PMCID PMC12996887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial.

  2024cited by this paper
• Evidence for a role of the basolateral amygdala in regulating regional metabolism in the stressed brain

  2024cited by this paper
• Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment

  2024cited by this paper
• Cell Adhesion Molecules in Schizophrenia Patients with Metabolic Syndrome

  2023cited by this paper
• Efficacy of low carbohydrate and ketogenic diets in treating mood and anxiety disorders: systematic review and implications for clinical practice

  2023cited by this paper
• Pilot study of a ketogenic diet in bipolar disorder

  2023cited by this paper
• Molecular and cellular evolution of the amygdala across species analyzed by single-nucleus transcriptome profiling

  2023cited by this paper
• Systemic Cell Adhesion Molecules in Severe Mental Illness: Potential Role of Intercellular CAM-1 in Linking Peripheral and Neuroinflammation.

  2022cited by this paper
• Shared mechanisms across the major psychiatric and neurodegenerative diseases

  2022cited by this paper
• Connecting omics signatures and revealing biological mechanisms with iLINCS

  2022cited by this paper
• Schizophrenia: a disorder of broken brain bioenergetics

  2022cited by this paper
• Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology

  2021cited by this paper
• Energy metabolism in major depressive disorder: Recent advances from omics technologies and imaging.

  2021cited by this paper
• The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment

  2021cited by this paper
• Abnormal Brain Bioenergetics in First-Episode Psychosis

  2021cited by this paper
• Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls.

  2020cited by this paper
• Single-nucleus transcriptome analysis reveals cell type-specific molecular signatures across reward circuitry in the human brain

  2020cited by this paper
• Neuronal diversity of the amygdala and the bed nucleus of the stria terminalis.

  2020cited by this paper
• Gene expression imputation and cell-type deconvolution in human brain with spatiotemporal precision and its implications for brain-related disorders

  2020cited by this paper
• Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis

  2020cited by this paper
• Similarities and dissimilarities between psychiatric cluster disorders

  2020cited by this paper
• Mechanisms of insulin resistance, mitochondrial dysfunction and the action of the ketogenic diet in bipolar disorder. Focus on the PI3K/AKT/HIF1-a pathway.

  2020cited by this paper
• Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016.

  2020cited by this paper
• Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

  2019cited by this paper
• Diurnal rhythms in gene expression in the prefrontal cortex in schizophrenia

  2019cited by this paper
• Ketosis and bipolar disorder: controlled analytic study of online reports

  2019cited by this paper
• Determining cell-type abundance and expression from bulk tissues with digital cytometry

  2019cited by this paper
• Amygdala NPY Circuits Promote the Development of Accelerated Obesity under Chronic Stress Conditions.

  2019cited by this paper
• Entrainment of Circadian Rhythms to Temperature Reveals Amplitude Deficits in Fibroblasts from Patients with Bipolar Disorder and Possible Links to Calcium Channels

  2019cited by this paper
• Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia

  2019cited by this paper
• Valence coding in amygdala circuits.

  2019cited by this paper
• Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments.

  2018cited by this paper
• L1000FWD: fireworks visualization of drug‐induced transcriptomic signatures

  2018cited by this paper
• A Next Generation Connectivity Map: L1000 Platform And The First 1,000,000 Profiles

  2017cited by this paper
• Inflammation, metaflammation and immunometabolic disorders

  2017cited by this paper
• The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence

  2017cited by this paper
• Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder

  2017cited by this paper
• Abnormalities in High-Energy Phosphate Metabolism in First-Episode Bipolar Disorder Measured Using 31P-Magnetic Resonance Spectroscopy.

  2017cited by this paper
• Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges

  2017cited by this paper
• Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference

  2017cited by this paper
• IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation

  2017cited by this paper
• Chronic fluoxetine treatment directs energy metabolism towards the citric acid cycle and oxidative phosphorylation in rat hippocampal nonsynaptic mitochondria.

  2017cited by this paper
• variancePartition: interpreting drivers of variation in complex gene expression studies

  2016cited by this paper
• Functional Characterization of Schizophrenia-Associated Variation in CACNA1C

  2016cited by this paper
• Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

  2016cited by this paper
• The role of inflammation in depression: from evolutionary imperative to modern treatment target

  2015cited by this paper
• From circuits to behaviour in the amygdala

  2015cited by this paper
• CACNB2: An Emerging Pharmacological Target for Hypertension, Heart Failure, Arrhythmia and Mental Disorders.

  2015cited by this paper
• Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis

  2015cited by this paper
• Amygdala Hyperactivity at Rest in Paranoid Individuals With Schizophrenia.

  2015cited by this paper
• Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder

  2015cited by this paper
• Erratum: Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons

  2015cited by this paper
• Metabolic regulation of immune responses.

  2014cited by this paper
• Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

  2014cited by this paper
• Analysis of ANK3 and CACNA1C variants identified in bipolar disorder whole genome sequence data

  2014cited by this paper
• Basolateral amygdala volume and cell numbers in major depressive disorder: a postmortem stereological study

  2014cited by this paper
• Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.

  2014cited by this paper
• A Specific Role for the REV-ERBα–Controlled L-Type Voltage-Gated Calcium Channel CaV1.2 in Resetting the Circadian Clock in the Late Night

  2014cited by this paper
• In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy.

  2014cited by this paper
• Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.

  2013cited by this paper
• A rare mutation of CACNA1C in a patient with Bipolar disorder, and decreased gene expression associated with a Bipolar-associated common SNP of CACNA1C in brain

  2013cited by this paper
• Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.

  2013cited by this paper
• STAR: ultrafast universal RNA-seq aligner

  2013cited by this paper
• The ketogenic diet: metabolic influences on brain excitability and epilepsy.

  2013cited by this paper
• Differentiating Patterns of Amygdala-Frontal Functional Connectivity in Schizophrenia and Bipolar Disorder

  2013cited by this paper
• Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables

  2013cited by this paper
• Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators.

  2013cited by this paper
• Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients

  2012cited by this paper
• Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

  2012cited by this paper
• Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder

  2011cited by this paper
• Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome.

  2010cited by this paper
• Genetic variation in CACNA1C affects brain circuitries related to mental illness.

  2010cited by this paper
• Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia.

  2010cited by this paper
• Genetic Variation in the &bgr;2 Subunit of the Voltage-Gated Calcium Channel and Pharmacogenetic Association With Adverse Cardiovascular Outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES)

  2010cited by this paper
• Abnormalities in mitochondrial structure in cells from patients with bipolar disorder.

  2010cited by this paper
• Ketones suppress brain glucose consumption.

  2009cited by this paper
• Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets

  2009cited by this paper
• edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

  2009cited by this paper
• Whole-genome association study of bipolar disorder

  2008cited by this paper
• Examining a bidirectional association between depressive symptoms and diabetes.

  2008cited by this paper
• Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder

  2008cited by this paper
• DrugBank: a knowledgebase for drugs, drug actions and drug targets

  2007cited by this paper
• Neuron numbers and volume of the amygdala in subjects diagnosed with bipolar disorder or schizophrenia.

  2007cited by this paper
• Regional cerebral glucose metabolic abnormalities in bipolar II depression.

  2007cited by this paper
• Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia?

  2005cited by this paper
• Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts.

  2005cited by this paper
• Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

  2004cited by this paper
• Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder.

  2003cited by this paper
• Low CSF somatostatin associated with response to nimodipine in patents with affective illness.

  2003cited by this paper
• Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels.

  2002cited by this paper
• Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.

  2001cited by this paper
• Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia.

  2001cited by this paper
• The use of nimodipine in the treatment of mood disorders.

  2000cited by this paper
• The stanley foundation brain collection and neuropathology consortium.

  2000cited by this paper
• Mitochondrial dysfunction in bipolar disorder.

  2000cited by this paper
• Prefrontal Cortical‐Amygdalar Metabolism in Major Depression

  1999cited by this paper
• Nimodipine Increases CSF Somatostatin in Affectively Ill Patients

  1995cited by this paper
• Calcium antagonists in manic-depressive illness.

  1993cited by this paper
• Verapamil: a new antimanic drug with potential interactions with lithium.

  1987cited by this paper
• Calcium antagonists in mania: a double-blind study of verapamil.

  1986cited by this paper

• SIRT3 attenuates chronic pain-induced depressive-like behaviors by deacetylating CypD at lysine 166 in central amygdala.

  2026cites this paper
• Insulin resistance and leptin dysregulation impact in vivo brain structure and cognitive functioning in mood disorders: a multimodal partial least squares path modeling study.

  2026cites this paper
• Brain and Blood Biomarkers of Major Depressive Disorder: A Systematic Review.

  2026cites this paper
• Molecular Signatures of Early-Onset Bipolar Disorder and Schizophrenia: Transcriptomic and Machine-Learning Insights into Calcium and cAMP Signaling, Including Sex-Specific Patterns

  2025cites this paper
• Increased Complement C4 in a Sparse Neuronal Subset Induces Network-Wide Transcriptomic Alterations in the Prefrontal Cortex

  2025cites this paper
• Schizophrenia recognition via eye movement features in video paradigm.

  2025cites this paper
• Altered molecular signaling pathways in the hippocampus of rhesus monkeys following chronic alcohol use

  2025cites this paper
• Investigating antidiabetic drug targets as potential therapeutic modulators for schizophrenia.

  2025cites this paper